bfPREPTM

bfPREP™ transforms raw, fragmented biomedical data into clean, harmonized, AI-ready assets you can trust.


blank

bfLEAP®

bfLEAP® uncovers biologically meaningful patterns, subgroups, and drivers hidden within complex, multimodal datasets.

blank

Coming Soon

Convert biological insight into ranked, explainable decisions that drive portfolio confidence.

BullFrog AI Platforms

bfPREP

bfPREP

Data Harmonization Platform

Data Extraction, Feature Engineering, Schema Design

Case Study: 10,000+ PDF scans into actionable data

Stage 1: Data Foundation

1
Stage 1

Clean Your Data

Remove errors and inconsistencies

2
Stage 2

Fix Your Units

Normalize measurements

3
Stage 3

Derive Features

Engineer meaningful features

4
Stage 4

Standardization

Harmonize data sets

CLEAN HARMONIZED AI-READY DATA

bfLEAP

bfLEAP

Biomedical Data Analysis

Subgroup and Driver Identification in Complex Datasets

Identifying drug response subgroups (ASCO GI 2026)

Biomedical Data Analysis

Quantify similarities & differences across patients, cohorts, or conditions

5
Stage 5

Compare Samples

Analyze cohort differences

6
Stage 6

ID Subgroups

Find patient clusters

BullFrog Data Networks®

7
Stage 7

Filter Artifacts

Remove noise & outliers

8
Stage 8

Interrogate Patterns

Explore relationships

9
Stage 9

Find Drivers

Identify key factors

BullFrog Data Networks®

EXPLAINABLE DRIVER-LEVEL INSIGHTS

Decision Arenas

Decision Arenas

COMING SOON

Decision & Strategy Platform

Decision Arenas

Learn more by signing up for our March 27th webinar.

Register for Webinar

bfPREPTM

  • Prepare clinical trial data for analysis
  • Harmonize multi-omics, and clinical data sets
  • Enable reliable AI/ML drug target discovery
  • Accelerate data readiness trust.

bfLEAP®

  • Identify responder and non-responder Patient subgroups
  • Discover novel drug targets and biomarkers
  • Understand disease heterogeneity
  • Understand disease mechanisms
  • Optimize translational insights from preclinical to clinical

Coming Soon

  • Prioritize Drug Targets and development program
  • Support indication selection and trial design decisions
  • Rank portfolio options by scientific and clinical impact
  • Build diversified, risk-balanced R&D portfolios

Whitepapers

Webinars